| 2-Pyridinecarbonitrile,6-acetyl- |
2-氰基-6-乙酰基吡啶 |
159307-02-5 |
| (S)-2-(piperazin-2-yl)acetonitrile |
S-2-哌嗪乙腈 |
1589082-26-7 |
| AZ191 |
DYRK1B抑制剂(AZ191) |
1594092-37-1 |
| 2- (9- phenyl- 9H-carbazol-3-yl)-10,10- dioxide-9H-thioxanthen-9- one |
TXO-PHCZ |
1623010-64-9 |
| ME401 |
ME401 |
1595129-71-7 |
| Cabazitaxel Impurity 15 |
卡巴他赛杂质 |
1584118-06-8 |
| FMoc-Val-Cit-PAB |
Fmoc-Val-Cit-PAB |
159858-22-7 |
| 4-(2-METHANESULFINYL-PHENYL)-PIPERIDINE(WXG00004) |
4-(2-(甲基亚磺酰基)苯基)哌啶 |
161609-95-6 |
| Sapitinib |
1593673-23-4 |
1593673-23-4 |
| TRANS-4-METHYL-N-[5-[2-(4-METHYLPIPERAZIN-1-YL)-2-OXOETHYL]-4-(2-THIENYL)-1,3-THIAZOL-2-YL]CYCLOHEXANECARBOXAMIDE |
化合物 GPR81 AGONIST 1 |
1620992-67-7 |
| Enfuvirtide |
恩夫韦地 |
159519-65-0 |
| N-[3-[[5-Fluoro-2-[[4-[(2-methoxyethoxy)methoxy]phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide |
N-[3-[[5-Fluoro-2-[[4-[(2-methoxyethoxy)methoxy]phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide |
1616380-54-1 |
| (4,4-dimethylcyclohexyl)boronic acid |
4,4-二甲基环己基硼酸 |
1609930-85-9 |
| ETHYL 4-(4-METHOXYPHENYL)-6-METHYL-2-OXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBOXYLATE |
ETHYL 4-(4-METHOXYPHENYL)-6-METHYL-2-OXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBOXYLATE |
161374-07-8 |
| N4-Benzoyl-2'-deoxy-5'-O-DMT-2'-fluoro-cytidine phosphoramidite |
N4-苯甲酰基-5'-O-DMT-2'-氟-脱氧胞苷-3'-氰乙氧基亚磷酰胺 |
161442-19-9 |
| 8-Bromoquinolin-6-ol |
8-Bromoquinolin-6-ol |
159925-99-2 |
| pyridine-3-sulfonyl chloride |
吡啶-3-磺酰氯 |
16133-25-8 |
| (S)-3-(4'-BENZYLOXYPHENYL)-2-HYDROXY-PROPIONIC ACID |
(S)-3-(4-(苄氧基)苯基)-2-羟基丙酸 |
162919-37-1 |
| Pyridoclax |
Pyridoclax |
1651890-44-6 |
| Tofacitinib Impurity 102 |
Tofacitinib Impurity 102 |
1615709-90-4 |
